SCHEMBL23348657

SCHEMBL23348657

COC(=O)CC1N=C(c2ccc(O)cc2)c2c(sc(C)c2C)-n2c(C)nnc21

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 20/20 0.84
ADORA3 P0DMS8 1/20 0.84
TSPO P30536 1/20 0.84
BRD2 P25440 5/20 0.71
BRD3 Q15059 4/20 0.71
BRDT Q58F21 4/20 0.69
CREBBP Q92793 2/20 0.69
HDAC3 O15379 1/20 0.69
JAK2 O60674 1/20 0.69
BRD1 O95696 1/20 0.69
CCL2 P13500 1/20 0.69
HDAC4 P56524 1/20 0.69
EP300 Q09472 1/20 0.69
HDAC1 Q13547 1/20 0.69
DNER Q8NFT8 1/20 0.69
HDAC7 Q8WUI4 1/20 0.69
HDAC2 Q92769 1/20 0.69
HDAC10 Q969S8 1/20 0.69
HDAC11 Q96DB2 1/20 0.69
HDAC8 Q9BY41 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21616151 1.00 BRD4 (0.84) BRD4ADORA3TSPOBRD2BRD3
SCHEMBL23320675 0.99 BRD4 (0.83) BRD4ADORA3TSPOBRD2BRD3
SCHEMBL23348599 0.92 BRD4 (0.83) BRD4ADORA3TSPOBRD2BRD3
SCHEMBL19465691 0.92 BRD4 (1.00) BRD4ADORA3TSPOBRD2BRD3
SCHEMBL12228301 0.92 BRD4 (1.00) BRD4ADORA3TSPOBRD2BRD3
SCHEMBL17051091 0.92 BRD4 (1.00) BRD4ADORA3TSPOBRD2BRD3
SCHEMBL23320757 0.92 BRD4 (0.74) BRD4ADORA3TSPOBRD2BRD3
SCHEMBL17854812 0.91 BRD4 (0.86) BRD4ADORA3TSPOBRD2BRD3
SCHEMBL23320674 0.91 BRD4 (0.82) BRD4ADORA3TSPOBRD2BRD3
SCHEMBL23321411 0.91 BRD4 (0.82) BRD4ADORA3TSPOBRD2BRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3819305-A1 AMIDE COMPOUND HAVING BET PROTEOLYSIS-INDUCING ACTION AND MEDICINAL APPLICATION THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2021-05-12 EP disclosed